<h4>Background</h4>Programmed death-ligand 1 (PD-L1) positivity is associated with a favorable response to immune checkpoint blockade (ICB) in urothelial bladder cancer (BLCA). The gene discussed is CD274; the disease is bladder transitional cell carcinoma.